- Home
- CATO vs VNRX Comparison
CATO vs VNRX Comparison
Compare CATO & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CATO
- VNRX
- Stock Information
- Founded
- CATO 1946
- VNRX N/A
- Country
- CATO United States
- VNRX United States
- Employees
- CATO N/A
- VNRX N/A
- Industry
- CATO Clothing/Shoe/Accessory Stores
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CATO Consumer Discretionary
- VNRX Health Care
- Exchange
- CATO Nasdaq
- VNRX Nasdaq
- Market Cap
- CATO 55.7M
- VNRX 52.4M
- IPO Year
- CATO N/A
- VNRX N/A
- Fundamental
- Price
- CATO $2.56
- VNRX $0.50
- Analyst Decision
- CATO
- VNRX Strong Buy
- Analyst Count
- CATO 0
- VNRX 4
- Target Price
- CATO N/A
- VNRX $4.17
- AVG Volume (30 Days)
- CATO 43.9K
- VNRX 263.7K
- Earning Date
- CATO 05-22-2025
- VNRX 05-15-2025
- Dividend Yield
- CATO 13.28%
- VNRX N/A
- EPS Growth
- CATO N/A
- VNRX N/A
- EPS
- CATO N/A
- VNRX N/A
- Revenue
- CATO $642,949,000.00
- VNRX $1,308,361.00
- Revenue This Year
- CATO N/A
- VNRX $563.72
- Revenue Next Year
- CATO N/A
- VNRX $160.43
- P/E Ratio
- CATO N/A
- VNRX N/A
- Revenue Growth
- CATO N/A
- VNRX 64.16
- 52 Week Low
- CATO $2.19
- VNRX $0.40
- 52 Week High
- CATO $6.70
- VNRX $0.90
- Technical
- Relative Strength Index (RSI)
- CATO 47.88
- VNRX 52.42
- Support Level
- CATO $2.50
- VNRX $0.40
- Resistance Level
- CATO $2.89
- VNRX $0.54
- Average True Range (ATR)
- CATO 0.19
- VNRX 0.05
- MACD
- CATO 0.01
- VNRX 0.00
- Stochastic Oscillator
- CATO 28.85
- VNRX 73.57
About CATO Cato Corporation (The)
The Cato Corp operates as a specialty retailer of fashion apparel and accessories in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.